# The Vaginal Health Trial

> **NCT02516202** · PHASE3 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 302 (actual)

## Conditions studied

- Atrophy of Vagina
- Menopause
- Dyspareunia (Female)

## Interventions

- **DRUG:** Vagifem
- **DEVICE:** Replens
- **OTHER:** Placebo tablet
- **OTHER:** Placebo gel

## Key facts

- **NCT ID:** NCT02516202
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2017-05
- **Final completion:** 2017-07
- **Target enrollment:** 302 (ACTUAL)
- **Last updated:** 2018-07-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02516202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02516202, "The Vaginal Health Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02516202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*